2014 ASCO Coverage: Advancing MPN Treatment Through Clinical Trials

At a roundtable discussion from the 2014 American Society of Clinical Oncology (ASCO) meeting, Dr. Ross Levine from Memorial Sloan Kettering Cancer Center and Dr. Olatoyosi Odenike from University of Chicago Medical Center joined Dr. Srdan Verstovsek from MD Anderson Cancer Center to review the latest advancement in the treatment of MPNs. The experts examine how the development of ruxolitinib (Jakafi®) has influenced enrollment in clinical trials. They also review the promises of combination therapy and how DNA tests will affect treatment moving forward.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube | http://www.youtube.com/pati...
Like on Facebook | http://www.fb.com/patientpo...
Follow on Twitter | http://www.twitter.com/pati...

Source: www.oncologytube.com

2014 ASCO Coverage: Advancing MPN Treatment Through Clinical Trials – http://flip.it/68r4J 

See on Scoop.itMyHealthShare Medical Reporter

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s